ArticleRadiology case reports2026
Pelizaeus-Merzbacher disease in children: A case report.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pelizaeus-Merzbacher disease (PMD) is a rare disease and can be defined as an X-linked recessive leukodystrophy. This is a progressive and unremitting disorder of myelination that results in serious neurological disability and currently has no specific treatment, causing severe impacts on patients and their families. This report presents a 3-year-1-month-old girl with PMD which had onset at age 2 due to gait disorder. She was detected with abnormalities on magnetic resonance imaging (MRI) and is in the process of finding the cause of the disease. PMD is a rare leukodystrophy with significant clinical implications for affected individuals and their families. Magnetic resonance imaging (MRI) is crucial for the early detection, characterization, diagnosis, and monitoring of leukodystrophies in general, and PMD in particular.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.